Research Analysts’ New Coverage for September 9th (A, ANIP, AVTR, BEN, BETR, BRKR, CHYM, CI, COLL, FCEL)

Research Analysts’ new coverage for Wednesday, September 9th:

UBS Group AG started coverage on shares of Agilent Technologies (NYSE:A). UBS Group AG issued a neutral rating and a $165.00 target price on the stock.

Leerink Partners began coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP). Leerink Partners issued an outperform rating and a $104.00 target price on the stock.

UBS Group AG started coverage on shares of Avantor (NYSE:AVTR). The firm issued a neutral rating and a $16.00 target price on the stock.

Keefe, Bruyette & Woods began coverage on shares of Franklin Resources (NYSE:BEN). The firm issued a market perform rating and a $38.00 price target on the stock.

B. Riley Financial, Inc. began coverage on shares of Better Home & Finance (NASDAQ:BETR). They issued a buy rating and a $26.00 price target on the stock.

UBS Group AG began coverage on shares of Bruker (NASDAQ:BRKR). UBS Group AG issued a neutral rating and a $65.00 target price on the stock.

Loop Capital initiated coverage on shares of Chime Financial (NASDAQ:CHYM). Loop Capital issued a buy rating and a $45.00 target price on the stock.

Evercore Inc started coverage on shares of Cigna Group (NYSE:CI). Evercore Inc issued an in-line rating and a $290.00 price target on the stock.

Leerink Partners initiated coverage on shares of Collegium Pharmaceutical (NASDAQ:COLL). They issued an outperform rating and a $45.00 target price on the stock.

Craig Hallum began coverage on shares of FuelCell Energy (NASDAQ:FCEL). Craig Hallum issued a buy rating and a $22.00 target price on the stock.

TD Cowen started coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH). TD Cowen issued a buy rating on the stock.

Jefferies Financial Group Inc. assumed coverage on shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK). They issued a buy rating and a $115.00 price target on the stock.

UBS Group AG assumed coverage on shares of Guardant Health (NASDAQ:GH). The firm issued a buy rating and a $225.00 price target on the stock.

UBS Group AG initiated coverage on shares of Illumina (NASDAQ:ILMN). They issued a buy rating and a $260.00 target price on the stock.

Keefe, Bruyette & Woods initiated coverage on shares of Invesco (NYSE:IVZ). They issued an outperform rating and a $39.00 price target on the stock.

Loop Capital began coverage on shares of Klarna Group (NYSE:KLAR). The firm issued a hold rating and a $18.00 price target on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Lithium Americas (NYSE:LAC). The firm issued an overweight rating and a $6.00 target price on the stock.

BMO Capital Markets assumed coverage on shares of lululemon athletica (NASDAQ:LULU). The firm issued an underperform rating and a $70.00 price target on the stock.

UBS Group AG began coverage on shares of Mettler-Toledo International (NYSE:MTD). UBS Group AG issued a neutral rating and a $1,460.00 target price on the stock.

UBS Group AG initiated coverage on shares of Myriad Genetics (NASDAQ:MYGN). UBS Group AG issued a neutral rating and a $3.60 target price on the stock.

Leerink Partners assumed coverage on shares of Nautilus Biotechnology (NASDAQ:NAUT). The firm issued an outperform rating and a $4.00 price target on the stock.

UBS Group AG assumed coverage on shares of Natera (NASDAQ:NTRA). The firm issued a buy rating and a $435.00 target price on the stock.

UBS Group AG initiated coverage on shares of Pacific Biosciences of California (NASDAQ:PACB). The firm issued a neutral rating and a $1.35 target price on the stock.

Leerink Partners started coverage on shares of Pacira BioSciences (NASDAQ:PCRX). They issued a market perform rating and a $28.00 target price on the stock.

Piper Sandler started coverage on shares of Primoris Services (NYSE:PRIM). The firm issued a neutral rating and a $90.00 target price on the stock.

UBS Group AG assumed coverage on shares of Repligen (NASDAQ:RGEN). They issued a buy rating and a $225.00 target price on the stock.

UBS Group AG started coverage on shares of Revvity (NYSE:RVTY). The firm issued a neutral rating and a $140.00 target price on the stock.

UBS Group AG initiated coverage on shares of Stevanato Group (NYSE:STVN). The firm issued a neutral rating on the stock.

UBS Group AG assumed coverage on shares of Tempus AI (NASDAQ:TEM). The firm issued a neutral rating and a $70.00 price target on the stock.

Leerink Partners assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA). They issued an outperform rating and a $45.00 target price on the stock.

BWS Financial started coverage on shares of Twist Bioscience (NASDAQ:TWST). The firm issued a sell rating and a $45.00 price target on the stock.

UBS Group AG initiated coverage on shares of Twist Bioscience (NASDAQ:TWST). They issued a neutral rating and a $144.00 target price on the stock.

UBS Group AG began coverage on shares of 10x Genomics (NASDAQ:TXG). UBS Group AG issued a neutral rating and a $68.00 target price on the stock.

UBS Group AG initiated coverage on shares of Waters (NYSE:WAT). They issued a buy rating and a $490.00 price target on the stock.

UBS Group AG initiated coverage on shares of West Pharmaceutical Services (NYSE:WST). The firm issued a buy rating and a $415.00 price target on the stock.